Asia Pacific Continuous Glucose Monitoring (CGM) Devices Market: New Product Innovation, Market Growth, Key Trends Analysis, and Forecast
- OI-53 |
- Published date: Jan, 2018 |
- Diabetes Care Devices |
- Pages
According to Optima Insights, the Asia Pacific Continuous Glucose Monitoring (CGM) Devices Market is estimated to be valued at US$ xxx million in 2017 and is projected to exhibit a CAGR of xx% over the forecast period (2019 – 2023).
Key Trends and Analysis of the Asia Pacific Continuous Glucose Monitoring (CGM) Devices Market:
Increasing pipeline products and favorable reimbursement policies by Center for Medicare & Medicaid Services (CMS) to strengthen the Asia Pacific Continuous Glucose Monitoring Devices market, over the forecast period. For instance, companies such as xxx, Inc, xxx Inc., etc are a few of the emerging companies which are expected to flourish the Asia Pacific Continuous Glucose Monitoring market, in a short span on 1 to 2 years. Additionally, there are players with promising disruptive technology in Continuous Glucose Monitoring to outstand the current CGM devices in the market.
Moreover, The Asia Pacific diabetes population is one of the major factors leading to the growth on Asia Pacific Continuous Glucose Monitoring Systems.
Key Market Takeaways:
- The Asia Pacific continuous glucose monitoring (CGM) devices market is expected to exhibit a CAGR of xx% during the forecast period (2019 – 2023), attributed to the integration of CGM data with insulin pump systems is now allowing some early forays into the automation of basal insulin infusion rates to reduce the risk of hypoglycemia.
- Market growth has been observed due to the edge on, by continuous glucose monitoring devices over traditional glucose monitoring devices with ease real-time glucose measurements, paving way to reduced chronic type II diabetes complications such as averting episodes of hypoglycemia causing reduced overall diabetes care costs and also improving quality of life for the patients
- Key market players operating in the Asia Pacific Continuous Glucose Monitoring (CGM) devices market includes xxx, xxx, xxx, etc…
Optima Insights, has a geographical / regional coverage on five major regions, including,
- North America,
- Latin America,
- Europe,
- Asia Pacific, and
- Middle East & Africa.
This extensive regional coverage also deep dives into major 26 countries, includes, U.S., Canada, Brazil, Mexico, Argentina, Rest of Latin America, U.K., Germany, France, Italy, Spain, Russia and Rest of Europe, India, China, Japan, Australia, South Korea, Australia, ASEAN, Rest of Asia Pacific, Israel, GCC, Rest of Middle East, North Africa, Central Africa and South Africa.
- North America,
- Latin America,
- Europe,
- Asia Pacific, and
- Middle East & Africa.
This extensive regional coverage also deep dives into major 26 countries, includes, U.S., Canada, Brazil, Mexico, Argentina, Rest of Latin America, U.K., Germany, France, Italy, Spain, Russia and Rest of Europe, India, China, Japan, Australia, South Korea, Australia, ASEAN, Rest of Asia Pacific, Israel, GCC, Rest of Middle East, North Africa, Central Africa and South Africa.
According to Optima Insights, the Asia Pacific Continuous Glucose Monitoring (CGM) Devices Market is estimated to be valued at US$ xxx million in 2017 and is projected to exhibit a CAGR of xx% over the forecast period (2019 – 2023).
Key Trends and Analysis of the Asia Pacific Continuous Glucose Monitoring (CGM) Devices Market:
Increasing pipeline products and favorable reimbursement policies by Center for Medicare & Medicaid Services (CMS) to strengthen the Asia Pacific Continuous Glucose Monitoring Devices market, over the forecast period. For instance, companies such as xxx, Inc, xxx Inc., etc are a few of the emerging companies which are expected to flourish the Asia Pacific Continuous Glucose Monitoring market, in a short span on 1 to 2 years. Additionally, there are players with promising disruptive technology in Continuous Glucose Monitoring to outstand the current CGM devices in the market.
Moreover, The Asia Pacific diabetes population is one of the major factors leading to the growth on Asia Pacific Continuous Glucose Monitoring Systems.
Key Market Takeaways:
- The Asia Pacific continuous glucose monitoring (CGM) devices market is expected to exhibit a CAGR of xx% during the forecast period (2019 – 2023), attributed to the integration of CGM data with insulin pump systems is now allowing some early forays into the automation of basal insulin infusion rates to reduce the risk of hypoglycemia.
- Market growth has been observed due to the edge on, by continuous glucose monitoring devices over traditional glucose monitoring devices with ease real-time glucose measurements, paving way to reduced chronic type II diabetes complications such as averting episodes of hypoglycemia causing reduced overall diabetes care costs and also improving quality of life for the patients
- Key market players operating in the Asia Pacific Continuous Glucose Monitoring (CGM) devices market includes xxx, xxx, xxx, etc…
Optima Insights, has a geographical / regional coverage on five major regions, including,
- North America,
- Latin America,
- Europe,
- Asia Pacific, and
- Middle East & Africa.
This extensive regional coverage also deep dives into major 26 countries, includes, U.S., Canada, Brazil, Mexico, Argentina, Rest of Latin America, U.K., Germany, France, Italy, Spain, Russia and Rest of Europe, India, China, Japan, Australia, South Korea, Australia, ASEAN, Rest of Asia Pacific, Israel, GCC, Rest of Middle East, North Africa, Central Africa and South Africa.
- North America,
- Latin America,
- Europe,
- Asia Pacific, and
- Middle East & Africa.
This extensive regional coverage also deep dives into major 26 countries, includes, U.S., Canada, Brazil, Mexico, Argentina, Rest of Latin America, U.K., Germany, France, Italy, Spain, Russia and Rest of Europe, India, China, Japan, Australia, South Korea, Australia, ASEAN, Rest of Asia Pacific, Israel, GCC, Rest of Middle East, North Africa, Central Africa and South Africa.
